test

Jon M. Plexico

@Stonepine Capital Management, Llc

Latest period2024 - Q3ReportedManaged Assets$158.248MTotal holdings38
Assets growth rate44.39%Assets growth rate (2-Q avg)15.67%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Stonepine Capital Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 38 positions.

Assets under management

The assets under management (AUM) of Stonepine Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 158.248M in assets, with a quarterly growth rate of 44.39% and a 2-quarter average growth rate of 15.67%. The portfolio is managed by Jon M. Plexico, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ADMAAdma Biologics Inc
Recent Activity
23.63%
$37.381M
1.87M shares@ $19.99 avg price
EOLSEvolus Inc
Recent Activity
Decreased -17.36%
14.03%
$22.191M
1.37M shares@ $16.2 avg price
GLPGGalapagos Nv
Recent Activity
Decreased -1.3%
8.71%
$13.781M
478,659 shares@ $28.8 avg price
JAZZJazz Pharmaceuticals Plc Us Listed
Recent Activity
New Position
3.88%
$6.128M
55,000 shares@ $111.41 avg price
RPRXRoyalty Pharma Plc
Recent Activity
New Position
3.79%
$5.997M
212,000 shares@ $28.29 avg price
XOMAXoma Corp
Recent Activity
Decreased -22%
3.27%
$5.166M
195,096 shares@ $26.48 avg price
RIGLRigel Pharmaceuticals Inc
Recent Activity
Increased 1.35%
3.17%
$5.001M
309,100 shares@ $16.18 avg price
ZVRAZevra Therapeutics Inc
Recent Activity
New Position
3.07%
$4.858M
700,000 shares@ $6.94 avg price
ANIKAnika Therapeutics Inc
Recent Activity
Increased 14.46%
2.96%
$4.676M
189,308 shares@ $24.71 avg price
RVNCRevance Therapeutics Inc
Recent Activity
Decreased -70.71%
2.69%
$4.256M
820,000 shares@ $5.19 avg price